On paper this is a friction-material company. In practice, the larger force inside the company is an investment portfolio. The friction bus...

Ronda Rousey news: Ronda Rousey, a pioneering figure in combat sports, amassed an estimated $14 million net worth by 2026 through UFC, WWE,...

Ankur Warikoo has announced the closure of his upskilling courses business, citing its lack of continued sense despite significant growth. ...

PLTR stock surges after 85% revenue growth as Palantir Technologies beats estimates and raises outlook. Palantir stock is outpacing Nvidia ...

Tips Music promoters are seeking to sell a minority stake to fund film content investments and strengthen music rights control. Previous ta...

Big Tech's March quarter 2026 earnings reveal a significant AI-driven transformation, with revenue up across the board. Companies are proje...

A listed company rarely operates alone. Behind it can sit a web of subsidiaries, step-down entities, associates, overseas arms, and special...

With the group set to reunite and embark on new projects, including a potential world tour, the financial trajectory of BTS members is expe...

Nestle, which presently pays 4.5% of its net sales as royalty towards its parent company, had sought shareholder approval for royalty payme...

Royalty payment of Maruti in the third quarter of FY18 stood at 5.3 per cent of sales.

Revenue growth for MNCs has been higher than that of S&P BSE 200 companies over the past five years and at margins that are comparable as w...

The rise in royalty payments to close to 3.15%, from 1.4%, of net sales by FY18 is likely to significantly impact the company’s bottom line.

During the five-year period, the aggregate net profit of the local arms of multi-national firms rose 20 pc and net sales by 70 pc.

Maruti Suzuki India reported a 4.95% rise in its net profit for the quarter ended Sept 30 at Rs 598.24 crore on the back of its highest-eve...

Companies such as Maruti Suzuki, Hero Honda, HUL and Nestle pay millions of dollars to their parent cos in technical and royalty fee. India...

Glenmark Pharmaceuticals Inc (GPI) has signed a $ 27 million royalty deal with international healthcare investment fund Paul Capital Partne...

IN a bid to liberalise the royalty regime, the department of industrial policy and promotion is planning to do away with the time-limit app...